Literature DB >> 33074480

Characterization of hereditary red blood cell membranopathies using combined targeted next-generation sequencing and osmotic gradient ektacytometry.

Joan-Lluis Vives-Corrons1,2, Elena Krishnevskaya3, Ines Hernandez Rodriguez4, Agueda Ancochea4.   

Abstract

Hereditary red blood cell (RBC) membranopathies are characterized by mutations in genes encoding skeletal proteins that alter the membrane complex structure. Hereditary spherocytosis (HS) is the most common inherited RBC membranopathy leading to hereditary hemolytic anemia with a worldwide distribution and an estimated prevalence, in Europe, of about 1:2000 individuals. The recent availability of targeted next generation sequencing (t-NGS) and its combination with RBC deformability measured with a laser-assisted optical rotational ektacytometer (LoRRca) has demonstrated to be the most powerful contribution to lower the percentage of hereditary hemolytic anemia undiagnosed cases. In order to know the kind and frequency of RBC membrane mutations in our geographical area (Catalonia) and to better understand their pathophysiology, 42 unrelated, non-transfusion-dependent (NTD) patients with hereditary hemolytic anemia have been studied by combining t-NGS and LoRRca. The osmoscan module of LoRRca provides three rheological profiles that reflect the maximal deformability (EImax), osmotic fragility (Omin), and hydration state (Ohyper) of RBCs and contribute to a better understanding of the contribution RBC rheology to the severity of anemia. From the 42 patients studied, 37 were suspected to be a RBC membrane defect due to phenotypic characteristics and abnormal RBC morphology and, from these, in 31 patients (83.8% of cases) the mutation was identified by t-NGS. No definite diagnosis was achieved in 11 patients (26.2% of cases), including 6 out of 37 cases, with suspected membranopathy, and 5 with unclassifiable HHA. In all these undiagnosed patients, the existence of hemoglobinopathy and/or enzymopathy was ruled out by conventional methods.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33074480     DOI: 10.1007/s12185-020-03010-9

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  2 in total

1.  Co-existence of hereditary spherocytosis and a new red cell pyruvate kinase variant: PK mallorca.

Authors:  R Zarza; M Moscardó; R Alvarez; J García; M Morey; A Pujades; J L Vives-Corrons
Journal:  Haematologica       Date:  2000-03       Impact factor: 9.941

Review 2.  Red cell membrane disorders.

Authors:  J Narla; N Mohandas
Journal:  Int J Lab Hematol       Date:  2017-05       Impact factor: 2.877

  2 in total
  8 in total

1.  A novel SPTB mutation causes hereditary spherocytosis via loss-of-function of β-spectrin.

Authors:  Shan Li; Ping Guo; Leyuan Mi; Xiaojing Chai; Kewang Xi; Ting Liu; Li Lu; Juan Li
Journal:  Ann Hematol       Date:  2022-01-31       Impact factor: 3.673

2.  Facilitating EMA binding test performance using fluorescent beads combined with next-generation sequencing.

Authors:  Andreas Glenthøj; Christian Brieghel; Amina Nardo-Marino; Richard van Wijk; Henrik Birgens; Jesper Petersen
Journal:  EJHaem       Date:  2021-09-09

3.  Rare anemias in adolescents.

Authors:  Joan Lluis Vives-Corrons; Elena Krishnevskaya
Journal:  Acta Biomed       Date:  2021-02-18

4.  Microfluidics Approach to the Mechanical Properties of Red Blood Cell Membrane and Their Effect on Blood Rheology.

Authors:  Claudia Trejo-Soto; Guillermo R Lázaro; Ignacio Pagonabarraga; Aurora Hernández-Machado
Journal:  Membranes (Basel)       Date:  2022-02-13

5.  Concomitant Hereditary Spherocytosis and Pyruvate Kinase Deficiency in a Spanish Family with Chronic Hemolytic Anemia: Contribution of Laser Ektacytometry to Clinical Diagnosis.

Authors:  Joan-Lluis Vives Corrons; Elena Krishnevskaya; Laura Montllor; Valentina Leguizamon; Marta Garcia Bernal
Journal:  Cells       Date:  2022-03-28       Impact factor: 6.600

6.  Effect of primary lesions in cytoskeleton proteins on red cell membrane stability in patients with hereditary spherocytosis.

Authors:  Cristina Vercellati; Anna Paola Marcello; Bruno Fattizzo; Anna Zaninoni; Agostino Seresini; Wilma Barcellini; Paola Bianchi; Elisa Fermo
Journal:  Front Physiol       Date:  2022-08-12       Impact factor: 4.755

7.  Targeted Next Generation Sequencing and Diagnosis of Congenital Hemolytic Anemias: A Three Years Experience Monocentric Study.

Authors:  Elisa Fermo; Cristina Vercellati; Anna Paola Marcello; Ebru Yilmaz Keskin; Silverio Perrotta; Anna Zaninoni; Valentina Brancaleoni; Alberto Zanella; Juri A Giannotta; Wilma Barcellini; Paola Bianchi
Journal:  Front Physiol       Date:  2021-05-21       Impact factor: 4.566

8.  Rare Anemias: Are Their Names Just Smoke and Mirrors?

Authors:  Greta Simionato; Richard van Wijk; Stephan Quint; Christian Wagner; Paola Bianchi; Lars Kaestner
Journal:  Front Physiol       Date:  2021-06-10       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.